These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
579 related articles for article (PubMed ID: 2004370)
21. Polymerization by DNA polymerase eta is blocked by cis-diamminedichloroplatinum(II) 1,3-d(GpTpG) cross-link: implications for cytotoxic effects in nucleotide excision repair-negative tumor cells. Chijiwa S; Masutani C; Hanaoka F; Iwai S; Kuraoka I Carcinogenesis; 2010 Mar; 31(3):388-93. PubMed ID: 20015866 [TBL] [Abstract][Full Text] [Related]
22. Antiproliferative activity of some cis-/trans-platinum(II) complexes on HeLa cells. Arandjelovic S; Tesic Z; Juranic Z; Radulovic S; Vrvic M; Potkonjak B; Ilic Z J Exp Clin Cancer Res; 2002 Dec; 21(4):519-26. PubMed ID: 12636098 [TBL] [Abstract][Full Text] [Related]
23. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin. Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031 [TBL] [Abstract][Full Text] [Related]
24. Mechanistic insights into antitumor effects of new dinuclear cis Pt(II) complexes containing aromatic linkers. Zerzankova L; Kostrhunova H; Vojtiskova M; Novakova O; Suchankova T; Lin M; Guo Z; Kasparkova J; Brabec V Biochem Pharmacol; 2010 Aug; 80(3):344-51. PubMed ID: 20399754 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and X-ray crystal structure of trans,cis-[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro. Kratochwil NA; Zabel M; Range KJ; Bednarski PJ J Med Chem; 1996 Jun; 39(13):2499-507. PubMed ID: 8691447 [TBL] [Abstract][Full Text] [Related]
26. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA. Knox RJ; Friedlos F; Lydall DA; Roberts JJ Cancer Res; 1986 Apr; 46(4 Pt 2):1972-9. PubMed ID: 3512077 [TBL] [Abstract][Full Text] [Related]
28. Theoretical analysis on the transition state of the anticancer drug trans-[PtCl2(isopropylamine)2] and its cis isomer binding to DNA purine bases. Zhou L J Phys Chem B; 2009 Feb; 113(7):2110-27. PubMed ID: 19173577 [TBL] [Abstract][Full Text] [Related]
29. Effect of geometric isomerism in dinuclear platinum antitumor complexes on DNA interstrand cross-linking. Kaspárková J; Nováková O; Vrána O; Farrell N; Brabec V Biochemistry; 1999 Aug; 38(34):10997-1005. PubMed ID: 10460154 [TBL] [Abstract][Full Text] [Related]
30. Synthesis, cytotoxicity, cell uptake and DNA interstrand cross-linking of 4,4'-dipyrazolylmethane-linked multinuclear platinum anti-cancer complexes. Wheate NJ; Cullinane C; Webster LK; Collins JG Anticancer Drug Des; 2001; 16(2-3):91-8. PubMed ID: 11962517 [TBL] [Abstract][Full Text] [Related]
31. Water soluble cationic trans-platinum complexes which induce programmed cell death in the protozoan parasite Leishmania infantum. Nguewa PA; Fuertes MA; Iborra S; Najajreh Y; Gibson D; Martínez E; Alonso C; Pérez JM J Inorg Biochem; 2005 Mar; 99(3):727-36. PubMed ID: 15708793 [TBL] [Abstract][Full Text] [Related]
32. Photoreactivity of platinum(II) in cisplatin-modified DNA affords specific cross-links to HMG domain proteins. Kane SA; Lippard SJ Biochemistry; 1996 Feb; 35(7):2180-8. PubMed ID: 8652559 [TBL] [Abstract][Full Text] [Related]
33. Instability of the monofunctional adducts in cis-[Pt(NH3)2(N7-N-methyl-2-diazapyrenium)Cl](2+)-modified DNA: rates of cross-linking reactions in cis-platinum-modified DNA. Payet D; Gaucheron F; Sip M; Leng M Nucleic Acids Res; 1993 Dec; 21(25):5846-51. PubMed ID: 8290343 [TBL] [Abstract][Full Text] [Related]
34. DNA cleavage and antitumour activity of platinum(II) and copper(II) compounds derived from 4-methyl-2-N-(2-pyridylmethyl)aminophenol: spectroscopic, electrochemical and biological investigation. Roy S; Maheswari PU; Lutz M; Spek AL; den Dulk H; Barends S; van Wezel GP; Hartl F; Reedijk J Dalton Trans; 2009 Dec; (48):10846-60. PubMed ID: 20023915 [TBL] [Abstract][Full Text] [Related]
35. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines. Yoshida M; Khokhar AR; Siddik ZH Cancer Res; 1994 Jul; 54(13):3468-73. PubMed ID: 8012968 [TBL] [Abstract][Full Text] [Related]
36. Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin. Donahue BA; Augot M; Bellon SF; Treiber DK; Toney JH; Lippard SJ; Essigmann JM Biochemistry; 1990 Jun; 29(24):5872-80. PubMed ID: 2383564 [TBL] [Abstract][Full Text] [Related]
37. Comparative studies on the mechanism of cytotoxic action of novel platinum II complexes with pyrazole ligands. Ciesielska E; Szulawska A; Studzian K; Ochocki J; Malinowska K; Kik K; Szmigiero L J Inorg Biochem; 2006 Oct; 100(10):1579-85. PubMed ID: 16842854 [TBL] [Abstract][Full Text] [Related]
38. Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand. Kasparkova J; Vojtiskova M; Natile G; Brabec V Chemistry; 2008; 14(4):1330-41. PubMed ID: 18022972 [TBL] [Abstract][Full Text] [Related]
39. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base. Roy S; Westmaas JA; Buda F; Reedijk J J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572 [TBL] [Abstract][Full Text] [Related]
40. G-G base-pairing in nucleobase adducts of the anticancer drug cis-[PtCl2(NH3)(2-picoline)] and its trans isomer. McGowan G; Parsons S; Sadler PJ Chemistry; 2005 Jul; 11(15):4396-404. PubMed ID: 15880542 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]